Interestingly, we found significantly elevated tyrosine kinase receptor MET levels in ccRCC tissues compared to healthy kidney tissue, in agreement with in vitro studies and ccRCC tissue analyses demonstrating upregulation of MET induced by inactivation of VHL (32, 33). The gene discussed is MET; the disease is nonpapillary renal cell carcinoma.